Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTICA: Single-Antiplatelet Therapy in NSTE-ACS
NCT04766437Phase 2Completed
- Sponsor
- University of Amsterdam
- Start
- Feb 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prasugrel, ticagrelor in non–ST-segment elevation acute coronary syndrome (NSTE-ACS), sponsored by University of Amsterdam. Started Feb 2021; status: completed.
02
Drugs
prasugrelticagrelor
03
Conditions
non–ST-segment elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on NCT04766437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04766437.